Riva Agostino

Associate Professor
SSD
MED/17 - INFECTIOUS DISEASES
Competition sector
06/D4 - SKIN, INFECTIOUS AND GASTROINTESTINAL DISEASES

Contacts

Workplace

Via Gian Battista Grassi, 74 - Ospedale Sacco - Pad. 19
20157 MILANO (MI)

Via Gian Battista Grassi, 74 - Ospedale Sacco - Pad. 56
20157 MILANO (MI)

Additional phone numbers
02 390426767
University email address
Teaching - Programme courses

Postgraduate programmes

A.Y. 2021/2022
Advanced course
A.Y. 2019/2020
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
Research

Publications

Publications
  • How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group / F. Ferretti, R. Cannatelli, M. Benucci, S. Carmagnola, E. Clementi, P. Danelli, D. Dilillo, P. Fiorina, M. Galli, M. Gallieni, G. Genovese, V. Giorgi, A. Invernizzi, G. Maconi, J.A. Maier, A.V. Marzano, P.S. Morpurgo, M. Nebuloni, D. Radovanovic, A. Riva, G. Rizzardini, G. Sabiu, P. Santus, G. Staurenghi, G. Zuccotti, P.C. Sarzi-Puttini, S. Ardizzone. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 12(2021), pp. 656362.1-656362.14.
  • Vaccinations in patients with multiple sclerosis : A Delphi consensus statement / A. Riva, V. Barcella, S.V. Benatti, M. Capobianco, R. Capra, P. Cinque, G. Comi, M.M. Fasolo, F. Franzetti, M. Galli, S. Gerevini, L. Meroni, M. Origoni, L. Prosperini, M. Puoti, C. Scarpazza, C. Tortorella, M. Zaffaroni, L. Moiola. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 27:3(2021), pp. 347-359. [10.1177/1352458520952310]
  • H3K4me3 Histone ChIP-Seq Analysis Reveals Molecular Mechanisms Responsible for Neutrophil Dysfunction in HIV-Infected Individuals / P. Piatek, M. Tarkowski, M. Namiecinska, A. Riva, M. Wieczorek, S. Michlewska, J. Dulska, M. Domowicz, M. Kulinska-Michalska, N. Lewkowicz, P. Lewkowicz. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 12(2021), pp. 682094.1-682094.18. [10.3389/fimmu.2021.682094]
  • N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 / M. McCallum, A. De Marco, F.A. Lempp, M.A. Tortorici, D. Pinto, A.C. Walls, M. Beltramello, A. Chen, Z. Liu, F. Zatta, S. Zepeda, J. di Iulio, J.E. Bowen, M. Montiel-Ruiz, J. Zhou, L.E. Rosen, S. Bianchi, B. Guarino, C.S. Fregni, R. Abdelnabi, S.-.C. Foo, P.W. Rothlauf, L.-. Bloyet, F. Benigni, E. Cameroni, J. Neyts, A. Riva, G. Snell, A. Telenti, S.P.J. Whelan, H.W. Virgin, D. Corti, M.S. Pizzuto, D. Veesler. - In: CELL. - ISSN 0092-8674. - 184:9(2021), pp. 2332-2347. [10.1016/j.cell.2021.03.028]
  • The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies : A Delphi consensus statement / L. Moiola, V. Barcella, S. Benatti, M. Capobianco, R. Capra, P. Cinque, G. Comi, M.M. Fasolo, F. Franzetti, M. Galli, S. Gerevini, L. Meroni, M. Origoni, L. Prosperini, M. Puoti, C. Scarpazza, C. Tortorella, M. Zaffaroni, A. Riva. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - 27:3(2021), pp. 331-346. [10.1177/1352458520952311]